REQUIRED FIELDS ARE MARKED IN BOLD. PLEASE NOTE THAT MISSING INFORMATION WILL DELAY OUR ABILITY TO ASSIST YOU IN ACCESSING SUPPORT
Vivimusta® (bendamustine HCl) injection 100 mg/4 mL (25 mg/mL) multi-dose vial
By signing below, I certify that (1) the above therapy is medically necessary and in the best interest of the patient listed above; (2) the information provided is complete
and accurate to the best of my knowledge; (3) I have obtained any and all authorizations and consents from the patient or the patient’s authorized personal representative necessary under HIPAA and state
law to release protected health information, including that contained on this form, to Azurity Pharmaceuticals and its affiliates, vendors, and agents for purposes relating to the Vivimusta CONNECTSM Program,
to solely assist with benefits verification, prior authorization/appeals assistance, and forwarding the above prescription by fax or other means of delivery to a licensed pharmacy to dispense Vivimusta where
appropriate; and (4) I agree to the Business Associate Agreement as presented at https://baa.vivimustaconnect.com/.